STEVEN LEIBOWITZ, M.D.
Specialist in LAS VEGAS, Nevada. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What stands out: STEVEN LEIBOWITZ, M.D. reported a CMS MIPS final score of 67.1493 out of 100, below the 83.1 national average, and filed 832 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.
STEVEN LEIBOWITZ, M.D. at a glance
Below national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Nevada
How Specialist compares to other specialties among Nevada providers
Specialist share within Nevada
Specialist is one of the more visible NUCC categories in Nevada
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
STEVEN LEIBOWITZ, M.D.'s 2023 MIPS final score plotted against the Specialist national average
- MIPS Final Score
- 67.1493/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Specialist) — 67.1493/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Specialist US NPIs
67.1493/100 MIPS final score — 16.0 pts below the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Specialist. Quality dim: 65.5762. Cost dim: 36.396.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
STEVEN LEIBOWITZ, M.D. is a Specialist provider practicing in LAS VEGAS, Nevada, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1679631014. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.
STEVEN LEIBOWITZ, M.D. appears in the CMS NPPES registry as a Specialist provider holding M.D. credentials at 653 N TOWN CENTER DR STE 102, LAS VEGAS, NV, 89144, with a listed phone of (702) 242-5555. NPI 1679631014 was issued on 12/05/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what LEIBOWITZ most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 832 prescription claims written by this provider, covering 334 Medicare beneficiaries and totaling roughly $377K in drug spend. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 67.1493/100 for the 2023 performance year (Quality 65.5762, Cost 36.396), compared with the national average of 83.1.
Specialist is a high-volume specialty nationwide, with 69,658 enrolled providers across 55 states and an average of 1,474 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1679631014 |
|---|---|
| Specialty | Specialist |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 12/05/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm STEVEN LEIBOWITZ, M.D.'s current license status, disciplinary history, and board certifications with the Nevada State Board of Medical Examiners in Nevada before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Individual
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for STEVEN LEIBOWITZ, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$24.4K
Largest payer
Amgen Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 1,091
- Total Day Supply
- 22,264
- Generic Drug Cost
- $22K
Patient Demographics
- Average Patient Age
- 75.2 years
- Avg HCC Risk Score
- 1.29
- Gender Split
- 58% female / 42% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
| Drug | Claims |
|---|---|
| Erythromycin Erythromycin Base | 278 |
| Tobramycin-Dexamethasone Tobramycin/Dexamethasone | 261 |
| Latanoprost | 108 |
| Restasis Cyclosporine | 29 |
| Ciprofloxacin Hcl | 18 |
| Prednisolone Acetate | 18 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 17 |
| Ketorolac Tromethamine | 15 |
| Timolol Maleate | 13 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Specialist Overview
How STEVEN LEIBOWITZ, M.D. fits within the Specialist landscape nationally.
STEVEN LEIBOWITZ, M.D.'s 832 claims are below the specialty average of 1,474.
Nearby Specialist Providers in Nevada
Other clinicians with the same primary specialty enrolled in Nevada, drawn from the same CMS NPPES roster as LEIBOWITZ.
Compare Specialist nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Nevada
Frequently Asked Questions
What is STEVEN LEIBOWITZ, M.D.'s specialty? ▼
How much does STEVEN LEIBOWITZ, M.D. prescribe under Medicare Part D? ▼
What is STEVEN LEIBOWITZ, M.D.'s Medicare quality score? ▼
Where is STEVEN LEIBOWITZ, M.D. located? ▼
What is STEVEN LEIBOWITZ, M.D.'s NPI number? ▼
How many Specialist providers are there in the US? ▼
What drugs does STEVEN LEIBOWITZ, M.D. prescribe most often? ▼
Does STEVEN LEIBOWITZ, M.D. accept Medicare? ▼
How can I verify STEVEN LEIBOWITZ, M.D.'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology